Authors:
Yu, R
Hebbar, V
Kim, DW
Mandlekar, S
Pezzuto, JM
Kong, ANT
Citation: R. Yu et al., Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways, MOLEC PHARM, 60(1), 2001, pp. 217-224
Citation: C. Chen et al., Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death, ARCH PH RES, 23(6), 2000, pp. 605-612
Authors:
Kong, ANT
Yu, R
Chen, C
Mandlekar, S
Primiano, T
Citation: Ant. Kong et al., Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis, ARCH PH RES, 23(1), 2000, pp. 1-16
Citation: R. Yu et al., Molecular mechanisms of butylated hydroxylanisole-induced toxicity: Induction of apoptosis through direct release of cytochrome c, MOLEC PHARM, 58(2), 2000, pp. 431-437
Authors:
Yu, R
Chen, C
Mo, YY
Hebbar, V
Owuor, ED
Tann, TH
Kong, ANT
Citation: R. Yu et al., Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism, J BIOL CHEM, 275(51), 2000, pp. 39907-39913
Authors:
Yu, R
Mandlekar, S
Lei, W
Fahl, WE
Tan, TH
Kong, ANT
Citation: R. Yu et al., p38 mitogen-activated protein kinase negatively regulates the induction ofphase II drug-metabolizing enzymes that detoxify carcinogens, J BIOL CHEM, 275(4), 2000, pp. 2322-2327
Citation: R. Yu et al., Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C, J BIOL CHEM, 275(13), 2000, pp. 9612-9619
Authors:
Yu, R
Mandlekar, S
Ruben, S
Ni, J
Kong, ANT
Citation: R. Yu et al., Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosisin androgen-independent prostate cancer cells, CANCER RES, 60(9), 2000, pp. 2384-2389
Authors:
Mandlekar, S
Hebbar, V
Christov, K
Kong, ANT
Citation: S. Mandlekar et al., Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: Activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines, CANCER RES, 60(23), 2000, pp. 6601-6606
Citation: S. Mandlekar et al., Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathwaysin tamoxifen-induced apoptosis of human breast cancer cells, CANCER RES, 60(21), 2000, pp. 5995-6000
Authors:
Shtil, AA
Mandlekar, S
Yu, R
Walter, RJ
Hagen, K
Tan, TH
Roninson, IB
Kong, ANT
Citation: Aa. Shtil et al., Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells, ONCOGENE, 18(2), 1999, pp. 377-384
Authors:
Kong, ANT
Mandlekar, S
Yu, R
Lei, W
Fasanmande, A
Citation: Ant. Kong et al., Pharmacodynamics and toxicodynamics of drug action: Signaling in cell survival and cell death, PHARM RES, 16(6), 1999, pp. 790-798
Authors:
Yu, R
Lei, W
Mandlekar, S
Weber, MJ
Der, CJ
Wu, J
Kong, ANT
Citation: R. Yu et al., Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals, J BIOL CHEM, 274(39), 1999, pp. 27545-27552
Authors:
Kong, ANT
Yu, R
Lei, W
Mandlekar, S
Tan, TH
Ucker, DS
Citation: Ant. Kong et al., Differential activation of MAPK and ICE/Ced-3 protease in chemical-inducedapoptosis - The role of oxidative stress in the regulation of mitogen-activated protein kinases (MAPKs) leading to gene expression and survival or activation of caspases leading to apoptosis, REST NEUROL, 12(2-3), 1998, pp. 63-70